Imisopasem manganese is primarily researched for its potential therapeutic applications in mitigating oxidative stress-related conditions. It is being studied as a mimetic of superoxide dismutase, an enzyme that plays a critical role in neutralizing superoxide radicals, which are harmful byproducts of cellular metabolism. This compound shows promise in preclinical studies for protecting tissues from damage caused by radiation therapy, particularly in cancer patients, by reducing oxidative stress and inflammation. Additionally, it is being explored for its potential in treating neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), where oxidative damage is a contributing factor. Its ability to scavenge reactive oxygen species makes it a candidate for applications in conditions involving chronic inflammation or ischemia-reperfusion injury. Ongoing research aims to further validate its efficacy and safety in clinical settings.